Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, A.
Right arrow Articles by Eto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, A.
Right arrow Articles by Eto, Y.
(Chest. 2006;130:1718-1722.)
© 2006 American College of Chest Physicians

Increased Leukotriene E4 in the Exhaled Breath Condensate of Children With Mild Asthma*

Atsushi Shibata, MD; Toshio Katsunuma, MD, PhD; Morimitsu Tomikawa, MD; Aiko Tan, MD; Keisuke Yuki, PhD; Kenichi Akashi, MD and Yoshikatsu Eto, MD, PhD

* From the Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan.

Correspondence to: Toshio Katsunuma, MD, PhD, Department of Pediatrics, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, 105-8461, Japan; e-mail: tkatsunuma{at}jikei.ac.jp

Abstract

Background: Chronic airway inflammation is a feature of asthma. Increased levels of cysteinyl leukotrienes (cys-LTs; leukotriene [LT]C4, LTD4, LTE4) have been shown in the exhaled breath condensate (EBC) of children with moderate-to-severe asthma. The aim of this study was to examine the relationship between EBC cys-LTs (LTE4) levels and bronchial hyperreactivity in children with mild asthma in order to evaluate the clinical utility of measuring EBC cys-LTs levels.

Methods: We measured LTE4 levels in the EBC of children aged 8 to 18 years, including healthy nonasthmatic children (n = 6) and children with mild asthma (n = 37). Patients with mild asthma were classified into the following three groups: group 1, participants who had been asymptomatic (no wheezing/symptoms of asthma) for > 6 months prior to examination (n = 12); group 2, participants who were asymptomatic but had had wheezing/symptoms of asthma within 6 months before examination (n = 18); and group 3, patients with current wheeze and/or mild symptoms of asthma exacerbation at the time of examination.

Results: Exhaled LTE4 levels were increased in all children with mild asthma compared with nonasthmatic control subjects (5.69 ± 9.62 pg/20 min vs 0.74 ± 0.79 pg/20 min, p < 0.05) [mean ± SD]. In particular, the EBC LTE4 levels in group 2 (4.99 ± 6.70 pg/20 min) and group 3 (14.66 ± 17.11 pg/20 min) were increased compared with control subjects and group 1 (1.50 ± 1.69 pg/20 min). The EBC LTE4 levels negatively correlated with the provocative concentration of methacholine causing a 15% fall in FEV1 (r = – 0.454, p = 0.012).

Conclusion: EBC cys-LTs may be useful as a noninvasive marker assessing airway inflammation and hyperreactivity in children with asthma.

Key Words: childhood asthma • exhaled breath condensate • leukotriene E4 • mild asthma






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Chest Physicians.